MARKET PULSE-Cooper Tire, Vanguard, Mondelez, Cubist, Vitran
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were little changed, in the wake of the best two-week advance for the S&P 500 in five months, and ahead of data on the housing market. S&P 500 futures rose 1.2 points, Dow Jones industrial average futures gained 13 points and Nasdaq 100 futures shed 0.5 points.
** SANOFI SA, Friday close $52.8
The French drugmaker's Lemtrada multiple sclerosis treatment has failed to win approval from regulators in the United States, dealing a setback to a drug which was at the heart of Sanofi's $20 billion takeover of U.S. biotech firm Genzyme. The U.S. Food & Drug Administration rejected Lemtrada for launch in the world's biggest drug market on the grounds that Genzyme had not shown its benefits outweighed its "serious adverse effects," the company said on Monday.
** COCA-COLA CO, Friday close $40.66, -100.00 pct premarket
The beverage maker's shares could see steep upside next year, following an extended period of relative underperformance compared with major indexes, Barron's wrote on Sunday. The financial publication also said Coca-Cola stands to benefit from a growing global middle class, which it estimated could result in a doubling of soft drink sales over the next 10 to 15 years.
** VANGUARD NATURAL RESOURCES LLC, Friday close $29.17, +0.10 pct premarket
The company said it entered into a definitive agreement to buy natural gas and oil properties in the Pinedale and Jonah fields of southwestern Wyoming for $581 million from an unnamed source. Continued...